Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

ImClone Systems News Editors

News Widget

Display the ImClone Systems news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

ImClone Systems News

News on ImClone Systems (Ticker: IMCL) continually updated from thousands of sources around the net.

Wednesday May 23 | CBS News

Stewart becomes non-executive chairman of company

NEW YORK &#8212 Martha Stewart was named as non-executive chairman of the lifestyle, media and merchandising company that she created Wednesday.

Comment?

Related Topix: Martha Stewart Living Omnimedia, Publishing, Media, Martha Stewart, Biotech, Medicine, Healthcare Industry

Thu Apr 26, 2012

Domain-B

Glaxo buys Genmab's leukemia drug for record $2.1 billion

Mumbai: GlaxoSmithKline Plc has bought global rights to Danish biotech company Genmab's leukemia drug for a record $2.1 billion, the firms said in statement.

Comment?

Related Topix: Leukemia, Health, Biotech, Medicine, Healthcare Industry, Lymphoma, Genentech, Startups, Bristol Myers Squibb

Domain-B

Amylin shares up as Icahn consolidates stake

Shares of biotechnology company Amylin gained as billionaire investor Carl Icahn is reported to have launched a power-play to place around five of his nominees to the company's board.

Comment?

Related Topix: Biotech, Medicine, Amylin Pharmaceuticals, Healthcare Industry, Diabetes, Health, Securities and Exchange Commission, Corporate / Securities Law, Law, Corporate Governance, Eli Lilly

Domain-B

Carl Icahn finds Bristol-Myers' offer for ImClone Systems low

ImClone Systems Incorporated, in which Bristol-Myers wants to raise its 17-per cent stake by acquiring the rest of the 83 per cent for $4.5 billion today said that its board of directors and large shareholders find the offer undevalued the firm.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Bristol Myers Squibb

Domain-B

Bristol-Myers Squibb raises bid for ImClone to $4.7 billion

Drugmaker Bristol-Myers Squibb Co has raised its offer for biotechnology firm ImClone Systems from the initial $60 a share to $62 a share, valuing the offer at around $4.7 billion.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Bristol Myers Squibb, Bloomsbury Publishing, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals

Los Angeles Jobs

Also on Topix